Engineered antigen‐binding fragments for enhanced crystallization of antibody:antigen complexes
Protein Science · 2024-01 · 33 (1)
DOI: 10.1002/pro.4824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 20.12.2023. Verfasst von Heather A Bruce und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Waterloo, Waterloo, Canada. Hauptthemen laut MEDLINE: Immunoglobulin Fab Fragments, Antigen-Antibody Complex. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Bristol-Myers Squibb, BMS.
Abstract (Originalsprache)
The atomic‐resolution structural information that X‐ray crystallography can provide on the binding interface between a Fab and its cognate antigen is highly valuable for understanding the mechanism of interaction. However, many Fab:antigen complexes are recalcitrant to crystallization, making the endeavor a considerable effort with no guarantee of success. Consequently, there have been significant steps taken to increase the likelihood of Fab:antigen complex crystallization by altering the Fab framework. In this investigation, we applied the surface entropy reduction strategy coupled with phage‐display technology to identify a set of surface substitutions that improve the propensity of a human Fab framework to crystallize. In addition, we showed that combining these surface substitutions with previously reported Crystal Kappa and elbow substitutions results in an extraordinary improvement in Fab and Fab:antigen complex crystallizability, revealing a strong synergistic relationship between these sets of substitutions. Through comprehensive Fab and Fab:antigen complex crystallization screenings followed by structure determination and analysis, we defined the roles that each of these substitutions play in facilitating crystallization and how they complement each other in the process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Waterloo, Waterloo, Canada.
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
- Ukko Inc., Rehovot, Israel.
- Department of Biochemistry, University of Toronto, Toronto, Canada.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
- Departments of Biochemistry and Molecular Genetics, University of Toronto, Ontario, Canada.
ORCID-Profile: Anthony A Kossiakoff
Förderung
- NIGMS NIH HHS
- Bristol-Myers Squibb
- BMS
Zitieren
APA
Bruce, H. A., Singer, A. U., Filippova, E. V., Blazer, L. L., Adams, J. J., Enderle, L., Ben-David, M., Radley, E. H., Mao, D. Y. L., Pau, V., Orlicky, S., Sicheri, F., Kurinov, I., Atwell, S., Kossiakoff, A. A., & Sidhu, S. S. (2024). Engineered antigen‐binding fragments for enhanced crystallization of antibody:antigen complexes. Protein Science, 33(1). https://doi.org/10.1002/pro.4824
Vancouver
Bruce HA, Singer AU, Filippova EV, Blazer LL, Adams JJ, Enderle L, et al. Engineered antigen‐binding fragments for enhanced crystallization of antibody:antigen complexes. Protein Science. 2024;33(1). doi:10.1002/pro.4824
BibTeX
@article{Bruce2024,
author = {Bruce, Heather A and Singer, Alexander U and Filippova, Ekaterina V and Blazer, Levi L and Adams, Jarrett J and Enderle, Leonie and Ben-David, Moshe and Radley, Elizabeth H and Mao, Daniel Y L and Pau, Victor and Orlicky, Stephen and Sicheri, Frank and Kurinov, Igor and Atwell, Shane and Kossiakoff, Anthony A and Sidhu, Sachdev S},
title = {Engineered antigen‐binding fragments for enhanced crystallization of antibody:antigen complexes},
journal = {Protein Science},
year = {2024},
volume = {33},
number = {1},
doi = {10.1002/pro.4824}
}
EUVIMED